Company page

Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc. (ticker: CGTX) is a public company based in the United States, with a market capitalization of approximately $129.77 million. The company focuses on developing therapies for neurodegenerative diseases. Its innovative approach aims to address significant unmet medical needs in the field of cognitive health.